 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
1 to 8 of 8 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
Ehlers M. on NEWS: Stop! Or I’ll...Ubiquitinate? Ligase Polices Runaway Proteins, This is a fascinating and elegant study that elucidates a key mechanism controlling the... 27 Sep 2010.
|
 |
 |
 |
 |
 |
Ehlers M. on PAPER: Wu Y. et al., 2007, The intriguing study by Wu et al. provides a clear link between AMPA receptors, the major... 4 Nov 2007.
|
 |
 |
 |
 |
 |
Ehlers M. on NEWS: AMPA Receptors: Going, Going, Gone in Aβ-exposed Synapses, PSD95 Knockouts, The study by Malinow and colleagues provides compelling evidence for a direct link between the... 16 Dec 2006.
|
 |
 |
 |
 |
 |
Ehlers M. on NEWS: Ataxia Proteins Tied Together in Disease-related Interactome, This remarkable study moves inherited neurodegenerative disorders into the era of protein... 28 May 2006.
|
 |
 |
 |
 |
 |
Ehlers M. on NEWS: Amyloid-β Zaps Synapses by Downregulating Glutamate Receptors, These papers provide intriguing evidence for a link among β-amyloid, excitatory synaptic... 19 Jul 2005.
|
 |
 |
 |
 |
 |
Ehlers M. on NEWS: Synaptic Activity—Ubiquitination or De-ubiquitination?, This paper demonstrates rapid Ca2+-dependent de-ubiquitination of synaptic proteins. Using a... 8 Dec 2003.
|
 |
 |
 |
 |
 |
Ehlers M. on PAPER: Wilson SM. et al., 2002, Ubiquitin and Synaptic Dysfunction: Ataxic Mice Highlight New Common Themes
in Neurologic... 8 Oct 2003.
|
 |
 |
 |
 |
 |
Ehlers M. on NEWS: Ubiquitin Protease Implicated in Ataxia, Ubiquitin and Synaptic Dysfunction: Ataxic Mice Highlight New Common Themes in Neurologic... 16 Oct 2002.
|
 |
 |
 |
 |
 |
 |
1 to 8 of 8 results |
|
 |
|
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Should the FDA be allowed to use data from overseas clinical trials? |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Absolutely, we are running out of viable subjects in the U.S. |
 |
 |
 |
 |
 |
 |
9 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Yes, so long as the data is reliable |
 |
 |
 |
 |
 |
 |
31 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the trials are not as rigorous |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the data should be repeated in the U.S. |
 |
 |
 |
 |
 |
 |
5 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
No, the drug sponsors are just trying to cut corners |
 |
 |
 |
 |
 |
 |
3 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Responses: 51 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
Archived Polls |
 |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |

|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
 |